Finance

Lists
000756:SHE
Shandong Xinhua Pharmaceutical Ord Shs A
CNÂ¥13.43
-0.15%
(-0.020) 1D
Aug 28, 3:04:15 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000756...
Open
CNÂ¥13.35
High
CNÂ¥13.52
Low
CNÂ¥13.30
Mkt. cap
7.69B
Avg. vol.
14.37M
Volume
6.06M
Dividend
1.12%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jul 10, 2026
P/E ratio
34.56
52-wk high
CNÂ¥18.70
52-wk low
CNÂ¥11.71
EPS
CNÂ¥0.39
Shares outstanding
501.68M
No. of employees
7K
Open
CNÂ¥13.35
High
CNÂ¥13.52
Low
CNÂ¥13.30
Mkt. cap
7.69B
Avg. vol.
14.37M
Volume
6.06M
Dividend
1.12%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jul 10, 2026
P/E ratio
34.56
52-wk high
CNÂ¥18.70
52-wk low
CNÂ¥11.71
EPS
CNÂ¥0.39
Shares outstanding
501.68M
No. of employees
7K
News stories
From web sources and news partners
About Shandong Xinhua Pharmaceutical Ord Shs A
CEO-
Employees7.02K
FoundedNov 1943
Headquarters-
SectorPharmaceutical industry
Websitexhzy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.12B
1.99B
2.42B
1.93B
Cost of goods sold
1.70B
1.70B
1.98B
1.54B
Cost of revenue
1.70B
1.70B
1.98B
1.54B
Research and development expenses
97.68M
81.51M
95.47M
97.22M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
211.30M
197.11M
198.38M
176.30M
Operating expense
297.65M
313.15M
307.72M
281.94M
Total operating expenses
2.00B
2.01B
2.29B
1.82B
Operating income
121.85M
-17.39M
133.38M
111.99M
Other non operating income
5.12M
-4.38M
-7.51M
-39.95M
EBT including unusual items
42.47M
52.92M
118.63M
46.31M
EBT excluding unusual items
111.70M
-28.30M
118.92M
86.35M
Income tax expense
6.73M
13.52M
35.37M
-18.38M
Effective tax rate
15.84%
25.56%
29.81%
-39.68%
Other operating expenses
-12.15M
37.37M
13.91M
8.37M
Net income
32.46M
33.67M
83.90M
65.22M
Net profit margin
1.53%
1.69%
3.46%
3.37%
Earnings per share
0.03
0.04
0.12
0.10
Interest and investment income
103.84K
4.92M
1.17M
14.65M
Interest expense
-7.31M
-13.67M
-8.45M
-
Net interest expenses
-7.21M
-8.75M
-7.28M
14.65M
Depreciation and amortization charges
-
-
-
-
EBITDA
256.56M
129.14M
279.91M
264.58M
Gain or loss from assets sale
1.71M
-1.99M
-
-93.38K
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps